Media and Games Invest SE

  • ISIN: MT0000580101
  • Land: Malta

Nachricht vom 17.09.2021 | 10:37

DGAP-DD: Media and Games Invest SE english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
17.09.2021 / 10:36
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Name and legal form: Bodhivas GmbH

2. Reason for the notification

a) Position / status
Person closely associated with:
First name: Remco
Last name(s): Westermann
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Media and Games Invest SE

b) LEI

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
Description: Ordinary A Share ISIN: MT0000580101

b) Nature of the transaction

c) Price(s) and volume(s)
Price(s) Volume(s)
53.8000 SEK 10006.80 SEK
53.8500 SEK 24663.30 SEK
53.9000 SEK 8031.10 SEK
53.9000 SEK 10294.90 SEK
53.9000 SEK 24740.10 SEK
53.9000 SEK 21452.20 SEK
53.9000 SEK 4851.00 SEK
53.9000 SEK 39832.10 SEK
53.9000 SEK 16331.70 SEK
53.9000 SEK 23446.50 SEK
54.0500 SEK 19512.05 SEK
54.1500 SEK 20089.65 SEK
53.6500 SEK 49572.60 SEK
53.8500 SEK 21270.75 SEK
53.8000 SEK 15171.60 SEK
53.8000 SEK 12374.00 SEK
53.7500 SEK 24886.25 SEK
53.6500 SEK 27898.00 SEK
53.4000 SEK 17248.20 SEK
53.4000 SEK 8277.00 SEK
53.4000 SEK 20719.20 SEK
53.4000 SEK 2029.20 SEK
53.4000 SEK 21253.20 SEK
53.5000 SEK 4922.00 SEK

d) Aggregated information
Price Aggregated volume
53.7702 SEK 448873.4000 SEK

e) Date of the transaction
2021-09-16; UTC+2

f) Place of the transaction
Name: Nasdaq First North Sweden

17.09.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktueller Webcast

Adler Group S.A.

Investor Call
Q3 2021

30. November 2021

Aktuelle Research-Studie

clearvise AG

Original-Research: clearvise AG (von First Berlin Equity Research GmbH): Buy

30. November 2021